131 related articles for article (PubMed ID: 11494307)
1. Antimicrotubular and cytotoxic activity of geiparvarin analogues, alone and in combination with paclitaxel.
Miglietta A; Bocca C; Gabriel L; Rampa A; Bisi A; Valenti P
Cell Biochem Funct; 2001 Sep; 19(3):181-9. PubMed ID: 11494307
[TBL] [Abstract][Full Text] [Related]
2. Geiparvarin and derivatives in combination with taxol: effect on microtubular organization in 3T3 fibroblasts.
Miglietta A; Bocca C; Rampa A; Bisi A; Gabriel L
Anticancer Drug Des; 1997 Dec; 12(8):607-20. PubMed ID: 9448701
[TBL] [Abstract][Full Text] [Related]
3. Cytoskeleton-interacting activity of geiparvarin, diethylstilbestrol and conjugates.
Bocca C; Gabriel L; Miglietta A
Chem Biol Interact; 2001 Sep; 137(3):285-305. PubMed ID: 11566295
[TBL] [Abstract][Full Text] [Related]
4. Interaction of geiparvarin and related compounds with purified microtubular protein.
Miglietta A; Bocca C; Gadoni E; Gabriel L; Rampa A; Bisi A; Valenti P; Da Re P
Anticancer Drug Des; 1996 Jan; 11(1):35-48. PubMed ID: 8639247
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-interfering activity of parthenolide.
Miglietta A; Bozzo F; Gabriel L; Bocca C
Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
[TBL] [Abstract][Full Text] [Related]
6. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
Gapud EJ; Bai R; Ghosh AK; Hamel E
Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
[TBL] [Abstract][Full Text] [Related]
8. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
Long BH; Carboni JM; Wasserman AJ; Cornell LA; Casazza AM; Jensen PR; Lindel T; Fenical W; Fairchild CR
Cancer Res; 1998 Mar; 58(6):1111-5. PubMed ID: 9515790
[TBL] [Abstract][Full Text] [Related]
9. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
Kovács P; Csaba G
Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
[TBL] [Abstract][Full Text] [Related]
10. Biological properties of jatrophane polyesters, new microtubule-interacting agents.
Miglietta A; Gabriel L; Appendino G; Bocca C
Cancer Chemother Pharmacol; 2003 Jan; 51(1):67-74. PubMed ID: 12497208
[TBL] [Abstract][Full Text] [Related]
11. Microtubule changes in hematologic malignant cells treated with paclitaxel and comparison with vincristine cytotoxicity.
Hirose Y; Takiguchi T
Blood Cells Mol Dis; 1995; 21(2):119-30. PubMed ID: 8846041
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
[TBL] [Abstract][Full Text] [Related]
13. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
Madari H; Panda D; Wilson L; Jacobs RS
Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
[TBL] [Abstract][Full Text] [Related]
14. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
15. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
Kingston DG; Chaudhary AG; Chordia MD; Gharpure M; Gunatilaka AA; Higgs PI; Rimoldi JM; Samala L; Jagtap PG; Giannakakou P; Jiang YQ; Lin CM; Hamel E; Long BH; Fairchild CR; Johnston KA
J Med Chem; 1998 Sep; 41(19):3715-26. PubMed ID: 9733497
[TBL] [Abstract][Full Text] [Related]
17. Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms.
Wang Y; Yin S; Blade K; Cooper G; Menick DR; Cabral F
Biochemistry; 2006 Jan; 45(1):185-94. PubMed ID: 16388594
[TBL] [Abstract][Full Text] [Related]
18. Bistratene A induces a microtubule-dependent block in cytokinesis and altered stathmin expression in HL60 cells.
Johnson WE; Watters DJ; Suniara RK; Brown G; Bunce CM
Biochem Biophys Res Commun; 1999 Jun; 260(1):80-8. PubMed ID: 10381347
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir.
Alexandre J; Nicco C; Chéreau C; Laurent A; Weill B; Goldwasser F; Batteux F
J Natl Cancer Inst; 2006 Feb; 98(4):236-44. PubMed ID: 16478742
[TBL] [Abstract][Full Text] [Related]
20. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.
Zheng X; Chang RL; Cui XX; Avila GE; Hebbar V; Garzotto M; Shih WJ; Lin Y; Lu SE; Rabson AB; Kong AN; Conney AH
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3444-51. PubMed ID: 16740769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
